Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.64M Buy
165,231
+13,691
+9% +$365K 0.3% 82
2025
Q4
$4.08M Sell
151,540
-515
-0.3% -$13K 0.26% 90
2025
Q3
$4.19M Sell
152,055
-15,309
-9% -$378K 0.27% 89
2025
Q2
$4.06M Sell
167,364
-17,983
-10% -$419K 0.28% 88
2025
Q1
$4.7M Sell
185,347
-32,174
-15% -$842K 0.34% 79
2024
Q4
$5.77M Sell
217,521
-2,423
-1% -$65.7K 0.4% 62
2024
Q3
$6.37M Sell
219,944
-10,437
-5% -$304K 0.43% 61
2024
Q2
$6.45M Buy
230,381
+21,319
+10% +$587K 0.46% 57
2024
Q1
$5.8M Buy
209,062
+11,250
+6% +$312K 0.42% 59
2023
Q4
$5.7M Buy
197,812
+10,421
+6% +$315K 0.45% 59
2023
Q3
$6.22M Buy
187,391
+36,829
+24% +$1.3M 0.6% 40
2023
Q2
$5.52M Sell
150,562
-5,128
-3% -$200K 0.79% 32
2023
Q1
$6.35M Sell
155,690
-4,178
-3% -$180K 0.93% 27
2022
Q4
$8.19M Sell
159,868
-3,007
-2% -$144K 1.19% 19
2022
Q3
$7.13M Sell
162,875
-1,668
-1% -$81.1K 1.16% 20
2022
Q2
$8.63M Buy
164,543
+1,037
+0.6% +$52.8K 1.32% 16
2022
Q1
$8.46M Sell
163,506
-3,887
-2% -$202K 1.13% 21
2021
Q4
$9.88M Sell
167,393
-3,599
-2% -$178K 1.27% 15
2021
Q3
$7.35M Sell
170,992
-3,728
-2% -$165K 1.02% 23
2021
Q2
$6.84M Buy
174,720
+265
+0.2% +$10.3K 0.94% 30
2021
Q1
$6.32M Sell
174,455
-2,310
-1% -$82K 0.91% 30
2020
Q4
$6.51M Sell
176,765
-5,414
-3% -$199K 0.99% 24
2020
Q3
$6.34M Buy
182,179
+1,361
+0.8% +$47.7K 1.06% 24
2020
Q2
$5.61M Sell
180,818
-9,631
-5% -$327K 1% 28
2020
Q1
$5.9M Buy
190,449
+608
+0.3% +$20.7K 1.21% 21
2019
Q4
$7.06M Sell
189,841
-807
-0.4% -$28.7K 1.11% 23
2019
Q3
$6.5M Sell
190,648
-4,687
-2% -$170K 1.14% 23
2019
Q2
$8.03M Sell
195,335
-1,342
-0.7% -$53.3K 1.44% 15
2019
Q1
$7.92M Sell
196,677
-3,252
-2% -$130K 1.44% 17
2018
Q4
$8.28M Sell
199,929
-1,105
-0.5% -$45.9K 1.34% 15
2018
Q3
$8.41M Sell
201,034
-10,290
-5% -$396K 1.36% 18
2018
Q2
$7.27M Sell
211,324
-68
-0% -$2.32K 1.3% 19
2018
Q1
$7.12M Sell
211,392
-837
-0.4% -$28.8K 1.16% 24
2017
Q4
$7.29M Sell
212,229
-15,946
-7% -$544K 1.15% 25
2017
Q3
$7.73M Sell
228,175
-14,695
-6% -$472K 1.24% 23
2017
Q2
$7.74M Buy
242,870
+1,120
+0.5% +$35.3K 1.26% 23
2017
Q1
$7.85M Sell
241,750
-1,059
-0.4% -$33.4K 1.3% 22
2016
Q4
$7.48M Buy
242,809
+1,618
+0.7% +$49.4K 1.29% 21
2016
Q3
$7.75M Buy
241,191
+1,300
+0.5% +$43.5K 1.35% 21
2016
Q2
$8.01M Sell
239,891
-5,878
-2% -$188K 1.4% 20
2016
Q1
$6.91M Sell
245,769
-6,015
-2% -$172K 1.21% 24
2015
Q4
$7.71M Sell
251,784
-2,105
-0.8% -$66.2K 1.38% 22
2015
Q3
$7.57M Sell
253,889
-15,004
-6% -$481K 1.41% 21
2015
Q2
$8.55M Sell
268,893
-3,436
-1% -$112K 1.4% 22
2015
Q1
$8.99M Sell
272,329
-11,024
-4% -$350K 1.43% 20
2014
Q4
$8.37M Sell
283,353
-752
-0.3% -$21.6K 1.31% 22
2014
Q3
$7.97M Sell
284,105
-18,984
-6% -$533K 1.28% 22
2014
Q2
$8.53M Sell
303,089
-27,115
-8% -$773K 1.29% 22
2014
Q1
$10.1M Sell
330,204
-4,157
-1% -$124K 1.46% 15
2013
Q4
$9.72M Sell
334,361
-2,174
-0.6% -$63.3K 1.39% 16
2013
Q3
$9.17M Sell
336,535
-1,033
-0.3% -$28.1K 1.37% 17
2013
Q2
$8.97M Buy
+337,568
New +$9.33M 1.35% 17

Other funds holding PFE

NBT Bank's PFE Position: Q1 2026 in Review

NBT Bank increased its Pfizer (PFE) stake by 9% in Q1 2026, buying an estimated $365K and bringing the position to 165,231 shares worth $4.64M. The position accounts for 0.3% of the portfolio, ranked #82.

NBT Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.1M in Q1 2014. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • NBT Bank held 165,231 shares of Pfizer worth $4.64M as of Q1 2026.
  • NBT Bank bought 13,691 Pfizer shares in Q1 2026, an estimated $365K.
  • Pfizer made up 0.3% of NBT Bank's portfolio in Q1 2026, its #82 holding.
  • NBT Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • NBT Bank's Pfizer position peaked at $10.1M in Q1 2014.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.